OurCrowd Portfolio Company SaNOtize Moves Forward with Anti-COVID Nitric Oxide Nasal Spray, Approved for Sale
OurCrowd portfolio company SaNOtize Research & Development Corp. has received interim approval to sell its COVID-19 treatment Nitric Oxide Nasal ...